科研速递论坛

标题: In a 'real-world', clinic-based community setting, sorafib dose of 400 mg/d... [打印本页]

作者: zxwy77 时间: 2013-8-19 09:34
标题: In a 'real-world', clinic-based community setting, sorafib dose of 400 mg/d...

题名	In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellualr carcimona, with better tolerance and similar survival.
链接	http://www.pulsus.com/journals/abstract.jsp?sCurrPg=journal&jnlKy=2&atlKy=12341&isuKy=1168&isArt=t

作者: dreamingfly 时间: 2013-8-19 09:34
http://pan.baidu.com/share/link? ... 13&uk=321439086

作者: wwjjdd 时间: 2013-8-19 09:37
本帖最后由 wwjjdd 于 2013-8-19 09:39 编辑

qqqqqqqqqqq

欢迎光临科研速递论坛 (http://www.expaper.cn/)